CAR-T therapy trial for tough blood cancer pulled before starting
Disease control
Terminated
This study aimed to test a new treatment called Anti-CD7 CAR-T cells for people with a hard-to-treat type of blood cancer (T-cell acute lymphoblastic leukemia/lymphoma) that had come back or not responded to standard therapy. The plan was to give the treatment to a small group of…
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated May 17, 2026 09:19 UTC